Starling Oncology, Inc. SEC filings STLN

Starling Oncology, Inc. has 544 filings in SEC EDGAR's recent list, going back to Jan 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Starling Oncology, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Aug 13, 2025 —
S-3/A Form s-3 amendment no. 1 Jun 16, 2025 —
S-3 Shelf registration Jun 6, 2025 —
S-3 Shelf registration May 8, 2025 —
424B3 Prospectus Feb 10, 2023 —
424B3 Prospectus Feb 10, 2023 —
POS AM Filing Jan 30, 2023 —
POS AM Filing Jan 30, 2023 —
424B3 Prospectus Jan 9, 2023 —
POS AM Filing Dec 30, 2022 —
424B3 Prospectus Dec 1, 2022 —
424B3 Prospectus Dec 1, 2022 —
424B3 Prospectus Dec 1, 2022 —
424B3 Prospectus Nov 10, 2022 —
424B3 Prospectus Nov 10, 2022 —
424B3 Prospectus Nov 10, 2022 —
424B3 Prospectus Sep 26, 2022 —
S-1/A Amended registration statement Sep 23, 2022 —
424B3 Prospectus Sep 22, 2022 —
424B3 Prospectus Sep 22, 2022 —
S-1 Registration statement Sep 8, 2022 —
424B3 Prospectus Aug 10, 2022 —
424B3 Prospectus Aug 10, 2022 —
424B3 Prospectus Aug 10, 2022 —
424B3 Prospectus Aug 10, 2022 —
424B3 Prospectus Aug 10, 2022 —
424B3 Prospectus Jun 3, 2022 —
S-1 Registration statement May 19, 2022 —
424B3 Prospectus May 12, 2022 —
S-8 Employee stock plan registration May 12, 2022 —
424B3 Prospectus May 11, 2022 —
424B3 Prospectus May 9, 2022 —
424B3 Prospectus May 6, 2022 —
POS AM Form s-1 Apr 29, 2022 —
424B3 Prospectus Apr 4, 2022 —
424B3 Prospectus Mar 11, 2022 —
424B3 Prospectus Mar 8, 2022 —
S-8 Employee stock plan registration Feb 22, 2022 —
424B5 Prospectus supplement Feb 14, 2022 —
S-1/A Amended registration statement Feb 9, 2022 —
S-1 Registration statement Dec 17, 2021 —
424B3 Prospectus Oct 22, 2021 —
S-4/A Filing Oct 20, 2021 —
S-4/A Filing Oct 4, 2021 —
S-4/A Filing Sep 7, 2021 —
S-4 Registration for a merger or exchange Jul 23, 2021 —
424B4 Prospectus Mar 12, 2020 —
S-1/A Amended registration statement Mar 5, 2020 —
S-1/A Amended registration statement Mar 4, 2020 —
S-1 Registration statement Feb 21, 2020 —

Showing 50 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cerritos, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1799191
Former names
Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.